Skip to main content
Fig. 6 | BMC Complementary Medicine and Therapies

Fig. 6

From: Krill oil supplementation reduces the growth of CT-26 orthotopic tumours in Balb/c mice

Fig. 6

Expression of pEGFR, EGFR, pAKT, AKT pERK ½, and ERK 1/2 following treatments with 15% of krill oil. The expression of pEGFR, EGFR, pAKT, AKT, pERK1/2, and ERK1/2 was analysed by western blotting in tumours following treatment with a 15% dietary krill oil supplementation compared to the untreated group A. The relative levels of pEGFR, pAKT, and pERK1/2 expression in tumour tissues after treatment with 15% krill oil compared to tumour tissues from untreated Balb/c mice B. N = 5 mice per group. The results are expressed as mean ± SEM, ***P < 0.001 compared to the untreated group

Back to article page